Nrx Pharmaceuticals Inc (NRXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 9,600 | 15,705 | 52,975 | 20,099 | 17,117 |
| Operating Income | -9,600 | -15,705 | -52,975 | -20,099 | -17,117 |
| Interest Expense | 0 | 3 | 3 | 5 | 5 |
| Other Income | 2,618 | 2,260 | 22,571 | -16,945 | 17,004 |
| Pre-tax Income | -6,982 | -13,448 | -30,407 | -37,049 | -118 |
| Net Income Continuous | -6,982 | -13,448 | -30,407 | -37,049 | -118 |
| Net Income | $-6,982 | $-13,448 | $-30,407 | $-37,049 | $-118 |
| EPS Basic Total Ops | -1.10 | -2.10 | 1.20 | -7.20 | -61.30 |
| EPS Basic Continuous Ops | -1.06 | -2.11 | -5.50 | -7.16 | -0.03 |
| EPS Diluted Total Ops | -1.10 | -2.10 | 4.20 | -7.20 | -64.30 |
| EPS Diluted Continuous Ops | -1.06 | -2.11 | -5.50 | -7.16 | -0.03 |
| EBITDA(a) | $-9,599 | $-15,704 | $-52,975 | $-20,098 | $-17,117 |